International Scholarly Research Notices has retracted the article titled “Innovative Therapies against Human Glioblastoma Multiforme” [1]. The article was found to contain a substantial amount of material from previously published articles, including the following sources:
(i) Lefranc F., Facchini V., and Kiss R. (2007): “Proautophagic Drugs: A novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas,” Oncologist 12, 1395–1403, https://doi.org/10.1634%2ftheoncologist.12-12-1395 [2] (cited as [129]).
(ii) Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, and Stegh A, et al.: “Malignant Astrocytic Glioma: Genetics, Biology, and Paths to Treatment,” Genes Dev 2007;21:2683–710, https://doi.org/10.1101/gad.1596707, Genes & Dev. 2007. 21: 2683-2710 [3] (not cited).
(iii) Elisabetta Benedetti: “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors,” PPAR Research, 2010, https://doi.org/10.1155%2f2010%2f427401 [4] (cited as [127]).
(iv) Ryuya Yamanaka: “Cell- and Peptide-Based Immunotherapeutic Approaches for Glioma,” Trends in Molecular Medicine, 2008, https://doi.org/10.1016%2fj.molmed.2008.03.003 [5] (cited as [2]).
(v) Azizul Haque: “Emerging Role of Combination of All-Trans Retinoic Acid and Interferon-gamma as Chemoimmunotherapy in the Management of Human Glioblastoma,” Neurochemical Research, 11/01/2007, https://doi.org/10.1007%2fs11064-007-9420-z [6] (cited as [121]).
CiminiA.IppolitiR.Innovative therapies against human glioblastoma multiforme201120111278749010.5402/2011/787490LefrancF.FacchiniV.KissR.Proautophagic drugs: A novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas20071212139514032-s2.0-3804902783810.1634/theoncologist.12-12-1395FurnariF. B.FentonT.BachooR. M.MukasaA.StommelJ. M.SteghA.Malignant astrocytic glioma: genetics, biology, and paths to treatment20072126832710BenedettiE.GalzioR.D'AngeloB.CerM. P.CiminiA.PPARs in human neuroepithelial tumors: PPAR ligands as anticancer therapies for the most common human neuroepithelial tumors20102010910.1155/2010/4274014274012-s2.0-77951577106YamanakaR.Cell- and peptide-based immunotherapeutic approaches for glioma200814522823510.1016/j.molmed.2008.03.003HaqueA.BanikN. L.RayS. K.Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma200732122203220910.1007/s11064-007-9420-z